Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of -9154.62% is 506% below its 3-year average of -1509.75%, near the low end of its 3-year range (-10568.26%–0.00%).
159.87% below its 12-month average of -3522.75%.
Reported quarterly operating margin; no daily interpolation. Q4 FY2025 (2025-12-31): -10568.26%.
OPERATING MARGIN
-9154.62%
OPERATING MARGIN AVG TTM
-3522.75%
OPERATING MARGIN AVG 3Y
-1509.75%
OPERATING MARGIN AVG 5Y
N/A
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-159.87%
CURRENT VS 3Y AVG
-506.37%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 489 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Cuprina Holdings (Cayman) Limited Class A Ordinary Shares
Market Cap
$6.03M
Operating Margin
-9154.62%
TTM Avg
-3522.75%
3Y Avg
-1509.75%
5Y Avg
N/A
Market Cap
$6.09M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
-71.62%
Market Cap
$6.10M
Operating Margin
-43737.46%
TTM Avg
-33857.66%
3Y Avg
-147235.02%
5Y Avg
-109633.70%
Market Cap
$6.10M
Operating Margin
-763.90%
TTM Avg
-929.35%
3Y Avg
-1043.46%
5Y Avg
-924.75%
Market Cap
$6.34M
Operating Margin
-119.54%
TTM Avg
-108.09%
3Y Avg
-117.27%
5Y Avg
-99.55%
Market Cap
$5.63M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$6.44M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$5.54M
Operating Margin
-305.03%
TTM Avg
-323.91%
3Y Avg
-495.10%
5Y Avg
-376.97%
Market Cap
$5.36M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR) | $6.03M | -9154.62% | -3522.75% | -1509.75% | N/A |
| Enlivex Therapeutics Ltd. (ENLV)vs › | $6.09M | 0.00% | 0.00% | 0.00% | -71.62% |
| Cardio Diagnostics Holdings, Inc. (CDIO)vs › | $6.10M | -43737.46% | -33857.66% | -147235.02% | -109633.70% |
| Femasys Inc. (FEMY)vs › | $6.10M | -763.90% | -929.35% | -1043.46% | -924.75% |
| Biomerica, Inc. (BMRA)vs › | $6.34M | -119.54% | -108.09% | -117.27% | -99.55% |
| Acurx Pharmaceuticals, Inc. (ACXP)vs › | $5.63M | 0.00% | 0.00% | 0.00% | 0.00% |
| Ensysce Biosciences, Inc. (ENSC)vs › | $6.44M | 0.00% | 0.00% | 0.00% | 0.00% |
| Intelligent Bio Solutions Inc. (INBS)vs › | $5.54M | -305.03% | -323.91% | -495.10% | -376.97% |
| Alzamend Neuro Inc (ALZN)vs › | $5.36M | 0.00% | 0.00% | 0.00% | 0.00% |
| Bolt Biotherapeutics, Inc. (BOLT)vs › | $6.72M | -450.07% | -699.99% | -986.00% | -5433.17% |
Gross Margin
-1.3%
Operating Margin
-9154.6%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2025-12-31 | -10568.26% |
| 2025-06-30 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-06-30 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-06-30 | 0.00% |
| 2022-12-31 | 0.00% |
